WHO Expects Emergency Use Decisions On Coronavirus Vaccines In Coming Weeks, Calls For More Funding To Supply Vaccines To LMICs

Reuters: WHO expects decisions on Pfizer, Moderna, AstraZeneca vaccines in weeks
“The World Health Organization expects to make decisions on whether to give emergency use approval to COVID-19 vaccines from Pfizer, Moderna and AstraZeneca in the coming weeks, its chief scientist said on Friday…” (Nebehay et al., 12/11).

Reuters: Any vaccine adverse effects up to national agencies to review — WHO
“Any adverse effects from COVID-19 vaccines are for national authorities to review, the World Health Organization said on Friday in response to questions about Britain warning people with a history of anaphylaxis to avoid the Pfizer-BioNTech shot…” (Nebehay/Farge, 12/11).

U.N. News: COVID-19 vaccines: Donors urged to step up funding for needy countries
“Addressing the financing gap to provide COVID-19 vaccines for everyone, everywhere, is an urgent priority, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Friday, in an appeal for stepped-up funding to support poorer countries. This week the United Kingdom began rollout of a vaccine developed by pharmaceutical companies Pfizer and BioNTech, and more nations are expected to follow suit very soon…” (12/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.